Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum consequat felis eu elit facilisis, sed posuere magna suscipit. Fusce urna elit, placerat quis blandit quis, mattis id ipsum. Vivamus ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...

The first CLOCS project showed that ovarian cancer patients started buying over-the-counter medications up to 8 or 9 months before their diagnosis, with their first GP visit regarding their symptoms ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021.It has been ten years since the World Health ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel?. The Regulation amounts to an ambitious and laudable step ...

Susan brings over 20 years of experience and knowledge within policy influencing and health service delivery, underpinned by strong academic, communication and project delivery skills. Most recently ...

Eamonn is a Consultant in Clinical Genetics at the Leeds Teaching Hospitals and Professor of Clinical Genetics at the University of Leeds. In October 2022, he was appointed to the Genomics England ...

The potential of polygenic scores to improve risk stratification has reignited enthusiasm around the use of genetic information to help predict and prevent common disease. A new report from the PHG ...

Exome sequencing is a relatively new technique that involves determination of the DNA sequence of the comparatively small proportion of the genome that is expressed as messenger RNA. The technique has ...

This report by PHG Foundation for NHS England, The personalised medicine technology landscape presents an independent evidence synthesis to inform the NHS as it continues to develop its approaches and ...

Chaitanya Erady is a policy analyst in the biomedical science division at PHG. She is passionate about exploring the potential of upcoming omics-based technologies in revolutionising the healthcare ...